SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 36.99%3B | 8.90%2.44B | -14.89%2.21B | -45.52%9.3B | -33.82%2.28B | -49.80%2.19B | -51.34%2.24B | -44.42%2.59B | 3.32%17.07B | -36.22%3.44B |
Operating revenue | 36.99%3B | 8.90%2.44B | -14.89%2.21B | -45.52%9.3B | -33.82%2.28B | -49.80%2.19B | -51.34%2.24B | -44.42%2.59B | 3.32%17.07B | -36.22%3.44B |
Cost of revenue | 38.78%2.62B | 11.40%2.14B | -14.23%1.92B | -45.94%8.05B | -33.35%2B | -49.79%1.89B | -52.14%1.92B | -45.57%2.24B | 3.78%14.9B | -36.04%3B |
Gross profit | 25.77%379.06M | -6.19%298.59M | -19.08%283.82M | -42.63%1.25B | -37.04%275.04M | -49.82%301.39M | -45.89%318.3M | -35.68%350.75M | 0.26%2.17B | -37.44%436.87M |
Operating expense | -9.12%77.54M | 6.97%74.67M | -7.66%69.05M | -11.89%305.54M | -29.41%75.64M | 15.76%85.32M | -15.19%69.8M | -10.54%74.78M | 35.41%346.76M | 43.24%107.16M |
Selling and administrative expenses | 23.42%7.59M | 26.67%8M | 6.19%6.78M | 14.90%27.91M | 11.66%9.07M | -1.44%6.15M | 7.25%6.31M | 57.71%6.38M | 51.58%24.29M | 46.37%8.12M |
-Selling and marketing expense | 23.42%7.59M | 26.67%8M | 6.19%6.78M | 14.90%27.91M | 11.66%9.07M | -1.44%6.15M | 7.25%6.31M | 57.71%6.38M | 51.58%24.29M | 46.37%8.12M |
Other operating expenses | -11.65%69.95M | 5.01%66.67M | -8.96%62.27M | -13.90%277.63M | -32.78%66.58M | 17.35%79.17M | -16.92%63.49M | -14.01%68.39M | 34.33%322.47M | 42.99%99.04M |
Operating profit | 39.55%301.52M | -9.89%223.92M | -22.17%214.78M | -48.48%939.93M | -39.52%199.4M | -58.99%216.07M | -50.89%248.5M | -40.24%275.97M | -4.45%1.82B | -47.12%329.71M |
Net non-operating interest income expense | -42.20%9.92M | -33.09%11.9M | -20.76%14.88M | 2,783.22%65.65M | 230.52%11.93M | 132.94%17.16M | 568.37%17.79M | 1,251.69%18.78M | -72.88%2.28M | -607.72%-9.14M |
Non-operating interest income | -42.20%9.92M | -33.09%11.9M | -20.76%14.88M | 175.69%70.45M | 27.63%16.73M | 118.97%17.16M | 554.12%17.79M | 892.34%18.78M | 190.16%25.55M | 492.81%13.11M |
Non-operating interest expense | ---- | ---- | ---- | -79.38%4.8M | ---- | ---- | ---- | ---- | 5,563.50%23.28M | --22.25M |
Other net income (expense) | 172.94%973K | 192.45%98K | -39.53%3.53M | 2.17%9.44M | 949.90%5.05M | -334.86%-1.33M | -164.63%-106K | -27.35%5.83M | 34.07%9.24M | -6.05%481K |
Other non- operating income (expenses) | 172.94%973K | 192.45%98K | -39.53%3.53M | 2.17%9.44M | 949.90%5.05M | -334.86%-1.33M | -164.63%-106K | -27.35%5.83M | 34.07%9.24M | -6.05%481K |
Income before tax | 34.72%312.41M | -11.37%235.92M | -22.42%233.18M | -44.71%1.02B | -32.60%216.38M | -56.64%231.89M | -47.68%266.18M | -36.21%300.58M | -4.61%1.84B | -48.70%321.05M |
Income tax | 35.12%82.49M | -13.67%60.77M | -15.82%62.78M | -44.61%263.25M | -46.17%57.23M | -49.42%61.05M | -44.39%70.39M | -38.72%74.58M | -6.03%475.29M | -38.13%106.31M |
Net income | 34.58%229.93M | -10.54%175.15M | -24.60%170.4M | -44.75%751.78M | -25.89%159.15M | -58.75%170.84M | -48.78%195.79M | -35.33%226M | -4.10%1.36B | -52.70%214.74M |
Net income continuous Operations | 34.58%229.93M | -10.54%175.15M | -24.60%170.4M | -44.75%751.78M | -25.89%159.15M | -58.75%170.84M | -48.78%195.79M | -35.33%226M | -4.10%1.36B | -52.70%214.74M |
Minority interest income | 169.02%352K | 68.42%-318K | 9,700.00%1.25M | -134.44%-1.1M | 109.39%426K | -985.11%-510K | -122.78%-1.01M | -100.39%-13K | -4.38%3.21M | -484.99%-4.54M |
Net income attributable to the parent company | 33.98%229.57M | -10.84%175.47M | -25.16%169.15M | -44.53%752.88M | -27.62%158.72M | -58.63%171.35M | -47.91%196.8M | -34.70%226.01M | -4.10%1.36B | -51.58%219.28M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 33.98%229.57M | -10.84%175.47M | -25.16%169.15M | -44.53%752.88M | -27.62%158.72M | -58.63%171.35M | -47.91%196.8M | -34.70%226.01M | -4.10%1.36B | -51.58%219.28M |
Basic earnings per share | 40.52%1.63 | -5.34%1.24 | -19.73%1.18 | -39.38%5.05 | -21.58%1.09 | -54.69%1.16 | -42.79%1.31 | -28.99%1.47 | -0.48%8.33 | -48.33%1.39 |
Diluted earnings per share | 40.52%1.63 | -4.62%1.24 | -19.31%1.17 | -39.35%5.01 | -21.01%1.09 | -54.33%1.16 | -42.73%1.3 | -29.27%1.45 | -0.12%8.26 | -48.12%1.38 |
Dividend per share | 0 | 5.80%0.73 | 0 | 2.99%1.38 | 2.99%0.69 | 0 | 2.99%0.69 | 0 | 15.52%1.34 | 15.52%0.67 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |